Title:
サルコペニアの予防剤及び治療剤
Document Type and Number:
Japanese Patent JP6991315
Kind Code:
B2
Abstract:
This invention relates to a preventive and/or therapeutic agent for sarcopenia, comprising a prostaglandin D2 production inhibitor as an active ingredient.
Inventors:
Zenki Inada
Daisuke Kajiwara
Daisuke Kajiwara
Application Number:
JP2020514431A
Publication Date:
January 12, 2022
Filing Date:
April 18, 2019
Export Citation:
Assignee:
National University Corporation Tokyo University of Agriculture and Technology
Taiho Pharmaceutical Co., Ltd.
Taiho Pharmaceutical Co., Ltd.
International Classes:
A61K31/4184; A61K31/454; A61K31/4545; A61K31/496; A61K31/5377; A61P21/00; A61P43/00
Foreign References:
| WO2011090062A1 | ||||
| WO2017150228A1 |
Other References:
裏出良博他,造血器型プロスタグランジンD合成酵素阻害薬によるDuchenne型筋ジストロフィーに対する進行軽減療法,医薬のあゆみ,2016年,Vol.259, No.1,p.37-42,要約、図3
KAJIWARA D et al.,Role of hematopoietic prostaglandin D synthase in biphasic nasal obstruction in guinea pig model of,European Journal of Pharmacology,2011年,Vol.667,p.389-395,390ページFig.1
KAJIWARA D et al.,Role of hematopoietic prostaglandin D synthase in biphasic nasal obstruction in guinea pig model of,European Journal of Pharmacology,2011年,Vol.667,p.389-395,390ページFig.1
Attorney, Agent or Firm:
Patent Business Corporation Saegusa International Patent Office